Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2025-10-10 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
普莱柯2025年半年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is a detailed announcement regarding the distribution of cash dividends for the half-year period of 2025 by 普莱柯生物工程股份有限公司. It includes specifics such as dividend per share, relevant dates (record date, ex-dividend date, payment date), tax treatment for different shareholder categories, and the approval of the distribution plan by a shareholders' meeting. The document is titled as a '权益分派实施公告' which translates to 'Implementation Announcement of Equity Distribution'. It does not contain comprehensive financial statements or analysis but focuses solely on dividend distribution details. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and related shareholder information. The document length is about 3064 characters, which is sufficient for a detailed dividend notice but not a full financial report. Therefore, the correct classification is DIV with high confidence.
2025-10-10 Chinese
北京德恒律师事务所关于普莱柯生物工程股份有限公司差异化分红事项的法律意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm regarding a company's differentiated dividend distribution plan. It references specific legal regulations, company resolutions, and detailed calculations related to dividend distribution and share repurchase. The document is a formal legal opinion rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements or earnings data but provides legal assurance on the compliance and legitimacy of the dividend plan. The document length is under 5,000 characters and is focused on legal opinion rather than the report itself or a simple announcement. Therefore, it does not fit categories like Annual Report, Earnings Release, or Dividend Notice. It is best classified under Regulatory Filings (RNS) as a legal opinion related to regulatory compliance and corporate actions that do not fit other specific categories.
2025-10-10 Chinese
普莱柯关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate. It details the approval by the Ministry of Agriculture and Rural Affairs, the product information, development background, and the impact on the company. There are no financial statements, earnings data, or detailed financial analysis. The document is an official announcement of a regulatory approval event rather than a financial report or management discussion. It fits best under Regulatory Filings (RNS) as it is a general regulatory announcement about a new product approval.
2025-09-29 Chinese
普莱柯2025年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions from the 2025 first extraordinary general meeting of shareholders of 普莱柯生物工程股份有限公司. It details the meeting date, attendance, voting results on profit distribution, and legal witness statements. The content is focused on the official voting results and meeting procedures rather than the meeting materials or presentations. The document length is short (1443 characters) and it is clearly a formal announcement of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-09-16 Chinese
北京德恒律师事务所关于普莱柯生物工程股份有限公司2025年第一次临时股东大会的法律意见
Regulatory Filings Classification · 90% confidence The document contains only references to omitted pictures and no textual content or financial data. The length is very short (601 characters), and there is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and defaults to Regulatory Filings (RNS) as a fallback category.
2025-09-16 Chinese
普莱柯2025年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2025 年第一次临时股东大会会议资料' which translates to '2025 First Extraordinary General Meeting (EGM) Materials'. It contains detailed information about the meeting organization, voting procedures, agenda, and a specific proposal regarding the 2025 half-year profit distribution plan. The document includes instructions for shareholders, voting methods, meeting agenda, and the profit distribution proposal with financial figures. The content is clearly related to materials shared for a shareholders' meeting, not the announcement of voting results or a report publication notice. It is not a full annual or interim report, nor an earnings release or management discussion. The document is a presentation of materials for the shareholders' meeting, which fits the definition of AGM Information (AGM-R), even though it is an extraordinary meeting, the category covers meeting materials. The document length is 3112 characters, which is short but contains substantive meeting materials, not just an announcement or notice. Therefore, the best classification is AGM Information (AGM-R).
2025-09-03 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.